Clinical and microbiological characteristics of bloodstream infection caused by Klebsiella pneumoniae harboring rmpA in Japanese adults

被引:7
|
作者
Kikuchi, Shota [1 ]
Kosai, Kosuke [2 ]
Ota, Kenji [2 ]
Mitsumoto-Kaseida, Fujiko [1 ]
Sakamoto, Kei [1 ]
Hasegawa, Hiroo [2 ]
Izumikawa, Koichi [3 ]
Mukae, Hiroshi [4 ]
Yanagihara, Katsunori [1 ,2 ]
机构
[1] Nagasaki Univ, Dept Lab Med, Grad Sch Biomed Sci, Nagasaki, Japan
[2] Nagasaki Univ Hosp, Dept Lab Med, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[3] Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, Nagasaki, Japan
[4] Nagasaki Univ, Dept Resp Med, Grad Sch Biomed Sci, Nagasaki, Japan
关键词
LIVER-ABSCESS; VIRULENCE; CAPSULE; K1; HYPERVIRULENT; BACTEREMIA;
D O I
10.1038/s41598-023-33265-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We investigated the clinical features of bloodstream infections (BSIs) caused by Klebsiella pneumoniae harboring rmpA and molecular characteristics of the bacteria. We retrospectively investigated adult patients with K. pneumoniae BSI from January 2010 to March 2021 at Nagasaki University Hospital. A matched case-control study in a 1:3 ratio was conducted to clarify the clinical and bacterial characteristics of BSI caused by rmpA-positive K. pneumoniae compared with those caused by rmpA-negative isolates. Antimicrobial susceptibility testing and multilocus sequence typing (MLST) were performed for rmpA-positive isolates. The rmpA was detected in 36 (13.4%) of the 268 isolates. Of these 36 isolates, 31 (86.1%) harbored iucA and 35 (97.2%) each possessed peg-344 and iroB; capsular types were identified as K1 in 9 (25.0%) and K2 in 10 isolates (27.8%). Contrarily, of the 108 rmpA-negative isolates, which were matched for case-control studies, 5 isolates (4.6%) harbored iucA and 1 (0.9%) each possessed peg-344 and iroB; 2 (1.9%) and 3 isolates (2.8%) had K1 and K2 capsular types, respectively. Among the rmpA-positive isolates, ST23/K1 (eight isolates) was the most frequent, followed by ST412/non-K1/K2 (seven isolates), ST86/K2 (five isolates), and ST268/non-K1/K2 (four isolates). In a multivariate analysis using clinical factors, liver abscess positively correlated with rmpA-positive isolates, whereas biliary tract infection and use of anticancer drugs negatively correlated with rmpA-positive isolates in patients with K. pneumoniae BSI. Considering the correlation between rmpA-positive isolates and clinical features, rmpA can be used as a marker for understanding the pathophysiology of K. pneumoniae BSI.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Association between clinical-biological characteristics of Klebsiella pneumoniae and 28-day mortality in patients with bloodstream infection
    Yu, Xiaofeng
    Zhao, Yi
    Sun, Xiao
    Luan, Jiahui
    Wang, Haiyan
    Sun, Tianyu
    Lin, Tongtong
    Zhou, Xia
    Yang, Wei
    Deng, Ziguang
    Liu, Bo
    Cao, Hongyun
    BMC MICROBIOLOGY, 2024, 24 (01):
  • [42] Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
    Zhang, Piaopiao
    Wang, Jie
    Hu, Hangbin
    Zhang, Sheng
    Wei, Juying
    Yang, Qing
    Qu, Tingting
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3233 - 3242
  • [43] Characteristics of Hypervirulent Klebsiella pneumoniae: Does Low Expression of rmpA Contribute to the Absence of Hypervirulence?
    Lin, Zhi-wei
    Zheng, Jin-xin
    Bai, Bing
    Xu, Guang-jian
    Lin, Fo-jun
    Chen, Zhong
    Sun, Xiang
    Qu, Di
    Yu, Zhi-jian
    Deng, Qi-wen
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [44] Clinical and Molecular Characteristics of Emerging Hypervirulent Klebsiella pneumoniae Bloodstream Infections in Mainland China
    Liu, Ying Mei
    Li, Bin Bin
    Zhang, Yu Yu
    Zhang, Wu
    Shen, Hong
    Li, Hui
    Cao, Bin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5379 - 5385
  • [45] Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study
    Guedes, Mariana
    Gathara, David
    Lopez-Hernandez, Inmaculada
    Perez-Crespo, Pedro Maria Martinez
    Perez-Rodriguez, Maria Teresa
    Sousa, Adrian
    Plata, Antonio
    Reguera-Iglesias, Jose Maria
    Boix-Palop, Lucia
    Dietl, Beatriz
    Blanco, Juan Sevilla
    Castillo, Carlos Arminanzas
    Galan-Sanchez, Fatima
    Kindelan, Clara Natera
    Jover-Saenz, Alfredo
    Aguirre, Josune Goikoetxea
    Aleman, Ana Aleman
    Ciordia, Teresa Marrodan
    Jimenez, Alfonso del Arco
    Fernandez-Suarez, Jonathan
    Lopez-Cortes, Luis Eduardo
    Rodriguez-Bano, Jesus
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2024, 23 (01)
  • [46] Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella pneumoniae Bloodstream Infections
    Song, Feizhen
    Zhang, Kai
    Huang, Jianjiang
    Qian, Zhenhua
    Zhou, Hongwei
    Cai, Jiachang
    Zheng, Cheng
    Zhou, Feifei
    Cui, Wei
    Zhang, Gensheng
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [47] Clinical characteristics of bacteremia caused by hypermucoviscous Klebsiella pneumoniae at a tertiary hospital
    Namikawa, Hiroki
    Yamada, Koichi
    Sakiyama, Arata
    Imoto, Waki
    Yamairi, Kazushi
    Shibata, Wataru
    Yoshii, Naoko
    Niki, Makoto
    Nakaie, Kiyotaka
    Oinuma, Ken-Ichi
    Tsubouchi, Taishi
    Niki, Mamiko
    Tochino, Yoshihiro
    Takemoto, Yasuhiko
    Kaneko, Yukihiro
    Shuto, Taichi
    Kakeya, Hiroshi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (01) : 84 - 88
  • [48] Multilocular infection caused by hypervirulent Klebsiella pneumoniae
    Tyll, T.
    Novotny, D.
    Beran, O.
    Bartakova, E.
    Pudil, J.
    Lesna, I. Kralova
    Rara, A.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2023, 72 (01): : 54 - 58
  • [49] Protective efficacy of statins in patients with Klebsiella pneumoniae bloodstream infection
    Xu, Qian
    Zheng, Beiwen
    Shen, Ping
    Xiao, Yonghong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 12
  • [50] Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
    Yu, Zhenwei
    Liu, Xiaofen
    Du, Xiaoxing
    Chen, Huiying
    Zhao, Feng
    Zhou, Zhihui
    Wang, Yu
    Zheng, Yang
    Bergen, Phillip J.
    Li, Xi
    Sun, Renhua
    Fang, Li
    Li, Wanzhen
    Fan, Yaxin
    Wu, Hailan
    Guo, Beining
    Li, Jian
    Yu, Yunsong
    Zhang, Jing
    FRONTIERS IN PHARMACOLOGY, 2022, 13